FLORHAM PARK, N.J., April 9 /PRNewswire/ -- Defined Health has
announced the final agenda and speaker list for its 8th annual Therapeutic
Insight conference. Therapeutic Insight 2008 ("TI2008") will take place on
April 28 - 30, 2008, at The Westin New York at Times Square. The following
industry decision-makers and key opinion leaders will discuss relevant
pharma/biotech issues and current trends in oncology, cardiovascular
disease, neuropsychiatric disorders, antimicrobials, therapeutic vaccines
and orphan diseases:
* Professor Ruth Arnon, The Paul Ehrlich Professor of Immunology,
Weizmann Institute of Science
* Charles Baum, MD, PhD, Vice President, Global R&D, Oncology, Pfizer
* Karen Bernstein, PhD, Chairman and Editor-in-Chief, BioCentury
* Thomas P. Blackburn, PhD, DSc, TPBioVentures LLC
* Jeffrey M. Bockman, PhD, Vice President, Defined Health
* Michael R. Bristow, MD, PhD, Founder, Chairman and Chief Science and
Medical Officer, ARCA Discovery
* Leslie J. Browne, PhD, President & CEO, Pharmacopeia Inc.
* Shannon Brownlee, Schwartz Senior Fellow, New American Foundation
* Michael D. Clayman, MD, CEO, Flexion Therapeutics
* Earl M. (Duke) Collier, Jr., JD, Executive Vice President, Genzyme
Corporation
* Albert R. Collinson, PhD, Chief Business Officer, Rib-X Pharmaceuticals
* Lode Debrabandere, PhD, Vice President & General Manager Inflammatory
Diseases, Osiris
* Mark W. Frohlich, MD, Senior VP & Chief Medical Officer, Dendreon
Corporation
* Matthew Gantz, Chief Executive Officer & Founder, Acureon Pharma
* Milton H. Grannatt, PhD, Vice President and Head, Negotiations, New
Growth Opportunities, Global Business Development & Licensing, Novartis
Pharmaceuticals Corporation
* Russell Hagan, PhD, Senior Vice President, Head of Research &
Development, BTG International
'/>"/>
| SOURCE Defined Health Copyright©2008 PR Newswire. All rights reserved |